New

New B. Braun venture seeking acceptance of genetic sequencing method

B. Braun, a global medical device manufacturer and pharmaceutical company located in the Lehigh Valley of Pennsylvania, announced a joint venture with German company CeGaT GmbH on next-generation sequencing technology, which it seeks to establish as the standard of diagnostic care for a variety of cancers, neuromuscular diseases, and epilepsy. The technology sequences DNA and RNA quickly and affordably, which helps doctors customize their treatment to specific conditions. Learn more about B. Braun.

Story Location

Translate »